Page 312 - Syndipharma
P. 312
Modava Pharmaceutical
No Type Brand Name Product Dosage Strength Indication Status
Form
16 Oncology EXJADE TAB DEFERASIROX TAB- FOR SUS- 500 mg Iron chelating agents In the
500MG LET, FOR SUSPEN- PENSION (Thalacemia) Market
SION ORAL 500 mg ORAL
17 Oncology JADENU 180 DEFERASIROX TAB- TABLET 180 mg Iron chelating agents In the
MG LET ORAL 180 mg ORAL (Thalacemia) Market IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
18 Oncology JADENU 360 DEFERASIROX TAB- TABLET 360 mg Iron chelating agents In the
MG LET ORAL 360 mg ORAL (Thalacemia) Market
19 Oncology JADENU 90 DEFERASIROX TAB- TABLET 90 mg Iron chelating agents In the
MG LET ORAL 90 mg ORAL (Thalacemia) Market
20 CNS LEPONEX TAB CLOZAPINE TABLET TABLET 100 mg ANTIPSYCHOTICS In the
100MG ORAL 100 mg ORAL Market
21 MS Marela HGC FINGOLIMOD CAP- CAPSULE 0.5 mg IMMUNOSUPPRES- In the
0.5MG SULE ORAL 0.5 mg ORAL SANTS Market
22 Organ transplanta- MYFORTIC MYCOPHENOLIC TABLET, 10 mg IMMUNOSUPPRES- In the
tion FCT360MG ACID TABLET, DE- DELAYED SANTS Market
LAYED RELEASE ORAL RELEASE
360 mg ORAL
23 CNS RITALIN TAB METHYLPHENIDATE TABLET 10 mg PSYCHOSTIMULANTS, In the
10MG HYDROCHLORIDE ORAL AGENTS USED FOR Market
TABLET ORAL 10 mg ADHD AND NOOT-
ROPICS
24 Organ transplanta- NEORAL SGC CICLOSPORIN CAP- CAPSULE 100 mg IMMUNOSUPPRES- In the
tion 100MG SULE ORAL 100 mg ORAL SANTS Market
25 Organ transplanta- NEORAL SGC CICLOSPORIN CAP- CAPSULE 25 mg IMMUNOSUPPRES- In the
tion 25MG SULE ORAL 25 mg ORAL SANTS Market
26 Organ transplanta- NEORAL SGC CICLOSPORIN CAP- CAPSULE 50 mg IMMUNOSUPPRES- In the
tion 50MG SULE ORAL 50 mg ORAL SANTS Market
27 CNS SIRDALUD TAB TIZANIDINE TABLET TABLET 4 mg MUSCLE RELAXANTS, In the
4MG ORAL 4 mg ORAL CENTRALLY ACTING Market
AGENTS
28 CNS TEGRETOL CR CARBAMAZEPINE TABLET, 200 mg ANTIEPILEPTICS In the
FCT 200MG TABLET, EXTENDED EXTENDED Market
RELEASE ORAL 200 RELEASE
mg ORAL
29 CNS TEGRETOL CR CARBAMAZEPINE TABLET, 400 mg ANTIEPILEPTICS In the
FCT 400MG TABLET, EXTENDED EXTENDED Market
RELEASE ORAL 400 RELEASE
mg ORAL
30 NSAID VOLTAREN FCT DICLOFENAC SODI- TABLET, 50 mg ANTIINFLAMMATORY In the
50MG UM TABLET, DELAYED EXTENDED AND ANTIRHEUMATIC Market
RELEASE ORAL 50 mg RELEASE PRODUCTS
ORAL
31 NSAID VOLTAREN SR DICLOFENAC TABLET, 100 mg ANTIINFLAMMATORY In the
75MG SODIUM TABLET, EXTENDED AND ANTIRHEUMATIC Market
EXTENDED RELEASE RELEASE PRODUCTS
ORAL 100 mg ORAL
32 NSAID VOLTAREN R DICLOFENAC TABLET, 75 mg ANTIINFLAMMATORY In the
FCT100MG SODIUM TABLET, EXTENDED AND ANTIRHEUMATIC Market
EXTENDED RELEASE RELEASE PRODUCTS
ORAL 75 mg ORAL
33 ANTIHISTAMINE ZADITEN TAB KETOTIFEN TABLET TABLET 1 mg ANTIHISTAMINES FOR In the
1MG ORAL 1 mg ORAL SYSTEMIC USE Market
311